• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Merge eFilm sales leap in 1Q

Article

Adoption of Fusion Server and eFilm Workstation contributed to Merge Technologies' 87% increase in net income during the first fiscal quarter of 2003. The image management company recorded net income of $1.32 million in the quarter ended March 31, 2003,

Adoption of Fusion Server and eFilm Workstation contributed to Merge Technologies' 87% increase in net income during the first fiscal quarter of 2003. The image management company recorded net income of $1.32 million in the quarter ended March 31, 2003, compared with $704,000 in the same period a year earlier. Net sales were up 35% to $6.12 million compared with $4.54 million in 1Q 2002. The results reflect success in targeting small and medium-sized hospitals and imaging centers while leveraging the company's installed base of the historical Merge eFilm product lines, said company president and CEO Richard Linden. The company affirmed guidance for 2003 revenues in the range of $27 million to $28 million with year-over-year growth of 30% to 35%.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.